phenylpropanolamine has been researched along with Cognition Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariogul, S; Cankurtaran, E; Cankurtaran, M; Ergen, A; Esin, E; Halil, M; Kuyumcu, ME; Ozcan, M; Ulger, Z; Yavuz, BB; Yeşil, Y | 1 |
| Jakobsen, SM; Kersten, H; Molden, E | 1 |
| Heilman, KM; Womack, KB | 1 |
| Cellar, J; Green, J; Jewart, RD; Lu, CJ; Tune, LE | 1 |
| Bolis, P; Cardozo, L; Salvatore, S; Serati, M; Uccella, S | 1 |
| Craig, B; Kritchevsky, S; Sands, LP; Sink, KM; Thomas, J; Xu, H | 1 |
7 other study(ies) available for phenylpropanolamine and Cognition Disorders
| Article | Year |
|---|---|
Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Benzofurans; Cognition Disorders; Cresols; Depression; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2015 |
Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.
Topics: Benzhydryl Compounds; Benzofurans; Biological Assay; Brain; Cognition Disorders; Cresols; Humans; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate | 2011 |
Tolterodine and memory: dry but forgetful.
Topics: Benzhydryl Compounds; Cognition Disorders; Cresols; Female; Humans; Memory Disorders; Mental Recall; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urination Disorders | 2003 |
Cognitive, behavioral, and physiological changes in Alzheimer disease patients as a function of incontinence medications.
Topics: Activities of Daily Living; Alzheimer Disease; Benzhydryl Compounds; Caregivers; Cholinergic Antagonists; Cognition Disorders; Cresols; Cross-Over Studies; Humans; Memory Disorders; Mental Disorders; Muscarinic Antagonists; Neuropsychological Tests; Phenylpropanolamine; Psychometrics; Single-Blind Method; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Incontinence; Wakefulness | 2005 |
Cognitive dysfunction with tolterodine use.
Topics: Aged; Benzhydryl Compounds; Cognition Disorders; Cresols; Female; Humans; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Benzhydryl Compounds; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Cresols; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Homes for the Aged; Humans; Male; Mandelic Acids; Neuropsychological Tests; Nursing Homes; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2008 |
[Phenylpropanolamine--psychological effects and confusion].
Topics: Brain; Cognition Disorders; Confusion; Humans; Phenylpropanolamine | 1979 |